Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Volitionrx (VNRX) Interest & Investment Income (2019 - 2025)

Volitionrx filings provide 7 years of Interest & Investment Income readings, the most recent being $122.0 for Q4 2025.

  • On a quarterly basis, Interest & Investment Income fell 61.02% to $122.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $600.0, a 93.97% decrease, with the full-year FY2025 number at $600.0, down 93.97% from a year prior.
  • Interest & Investment Income hit $122.0 in Q4 2025 for Volitionrx, down from $160.0 in the prior quarter.
  • In the past five years, Interest & Investment Income ranged from a high of $67157.0 in Q4 2022 to a low of $2.0 in Q1 2022.
  • Median Interest & Investment Income over the past 5 years was $471.0 (2021), compared with a mean of $11593.5.
  • Biggest five-year swings in Interest & Investment Income: tumbled 99.88% in 2022 and later surged 2882300.0% in 2023.
  • Volitionrx's Interest & Investment Income stood at $231.0 in 2021, then surged by 28972.29% to $67157.0 in 2022, then plummeted by 87.59% to $8337.0 in 2023, then tumbled by 96.25% to $313.0 in 2024, then crashed by 61.02% to $122.0 in 2025.
  • The last three reported values for Interest & Investment Income were $122.0 (Q4 2025), $160.0 (Q3 2025), and $160.0 (Q2 2025) per Business Quant data.